Low expression of CD24 is associated with poor survival in colorectal cancer-Reference-Cited by-同舟云学术

Low expression of CD24 is associated with poor survival in colorectal cancer

Published:2022-01 Issue: Volume:192 Page:91-101
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Nersisyan Stepan,Ahlers Ann-Kristin,Lange Tobias,Wicklein Daniel,Galatenko Alexei,Bohnenberger Hanibal,Elakad Omar,Conradi Lena-Christin,Genduso Sandra,Maar Hanna,Schiecke Alina,Maltseva Diana,Raygorodskaya Maria,Makarova Julia,Schumacher Udo,Tonevitsky Alexander

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference47 articles.

1. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells;Aigner;Blood,1997

2. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity;Jaggupilli;Clin. Dev. Immunol.,2012

3. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy;Barkal;Nature,2019

4. Molecular mechanism of tumor cell immune escape mediated by CD24/Siglec-10;Yin;Front. Immunol.,2020

5. CD24 expression is a new prognostic marker in breast cancer;Kristiansen;Clin. Canc. Res.,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incautious design of shRNAs for stable overexpression of miRNAs could result in generation of undesired isomiRs;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2024-09

2. Targeting the CD24-Siglec10 Axis: A Potential Strategy for Cancer Immunotherapy;BIO Integration;2024

3. Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria‐related pathways in colorectal cancer;Molecular Oncology;2023-11-03

4. CD24: A Novel Target for Cancer Immunotherapy;Journal of Personalized Medicine;2022-07-28